Table 2:
V2G-qPCR Master Mix Reagents | Volume per Duplexed 40 uL Reaction | |
| ||
Nuclease-free water | 23.31 μL | |
| ||
5X Volcano (2G) Buffer (myPOLS LOT# 8016) | 8.8 μL | |
| ||
10 mM dNTPs | 1.2 μL | |
| ||
5 units/pL Volcano (2G) Polymerase (myPOLS LOT# 110521NRA) | 0.5 μL | |
| ||
5 units/pL Taq Antibody (TaKaRa Cat# 9002A) | 0.25 μL | |
| ||
20 μM forward primer | 0.8 μL | |
| ||
20 μM reverse primer | 0.8 μL | |
| ||
100 μM target-specific FAM probe | 0.16 μL | |
| ||
100 μM target-specific HEX probe | 0.12 μL | |
| ||
400X Rox | 0.1 μL | |
| ||
MgCl2 | 0.4 μL | |
| ||
V2G-qPCR Master Mix Reagents | Volume per Singleplexed 40 uL Reaction | |
| ||
Nuclease-free Water | 23.6 μL | |
| ||
5X Volcano (2G) Buffer (myPOLS LOT# 8016) | 8.8 μL | |
| ||
10 mM dNTPs | 0.8 μL | |
| ||
5 units/pL Volcano (2G) Polymerase (myPOLS LOT# 110521NRA) | 0.4 μL | |
| ||
5 units/pL Taq Antibody (TaKaRa Cat# 9002A) | 0.2 μL | |
| ||
20 μM forward primer | 1 μL | |
| ||
20 μM reverse primer | 1 μL | |
| ||
100 μM target-specific FAM/HEX probe | 0.1 μL | |
| ||
400X Rox | 0.1 μL | |
| ||
Molecular Target | Primer/Probe Sequences | |
| ||
SARS-CoV-2 (N3) | CV3b/f | TGCTAACAAAGACGGCATCA |
CV3c/r | GTAGCACGATT GCAGCATT G | |
CV3.prb | ACA TTG GCA CCC GCA ATC CTG CT (FAM) | |
| ||
SIV | SIV876/f | GCTAGACT CT CACCAGCACTT G |
SIV999/r | CTAGGAGAGATGGGAACACACA | |
SIV.prb | TCCACGCTTGCTTGCTTAAAGACCTCT (FAM) | |
| ||
PMMoV | PMMoV/f | AGTGGTTTGACCTT AACGTTT GA |
PMMoV/r | CCTACGTCTGACGACACAATCT | |
PMMoV.prb | CCTACCGAAGCAAATGTCGCACT (HEX) | |
| ||
B2M | qB2M/f | CAAGGACT GGTCTTT CTATCTCTTGTAC |
qB2M/r | CTGCTTACATGTCTCGATCCC | |
B2M.prb | AGCAGCGGCAGGACCAGCCCCAAG (FAM) | |
| ||
HIV | RTwt3/f | GAAAATTAGTAGATTT CAGAGAACTTAAT AAGAGAAC |
V106/r | CATCACCCACATCCAGTACTGTTA | |
RT1.prb | TTCTGGGAAGTTCAATTAGGAATACCACATCCCGCAGG (FAM) | |
| ||
OC43 | OC43/f | CAACCAGGCTGATGT CAATAC |
OC43/r | AAACCTAGTCGGAATAGCCTCA | |
OC43.prb | ACATTGTCGATCGGGACCCAAGT (HEX) |